Status:
TERMINATED
Measurement of Substance P in Saliva of Low Back Pain Patients
Lead Sponsor:
Kovacs Foundation
Conditions:
Low Back Pain
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to compare the levels of Substance P in saliva, in patients with severe chronic low back pain and in subjects without it. In addition, to explore a possible cutoff point, ...
Eligibility Criteria
Inclusion
- Patients referred to the Kovacs Back Pain Unit in Palma de Mallorca for chronic low back pain
- A pain level of 6 or greater on the PI-NRS scale (0=no pain, 10= worst pain possible)
- Seen at the Unit between 9 and 13 hours (due to the circadian rhythm of Substance P in saliva and to avoid great variability in the results)
- For healthy subjects:
- Volunteers with no pain (anywhere)
- That in the past year have had no more than 40 days with pain, and no episode of more than 7 days of continuous pain.
Exclusion
- Subjects with pain that is additional to or different from chronic low back pain
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00735735
Start Date
February 1 2009
End Date
March 1 2014
Last Update
August 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kovacs Foundation
Palma de Mallorca, Balearic Islands, Spain, 07012